Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

6.84USD
3:59pm EST
Change (% chg)

$0.12 (+1.79%)
Prev Close
$6.72
Open
$6.80
Day's High
$7.14
Day's Low
$6.60
Volume
7,019
Avg. Vol
21,830
52-wk High
$19.00
52-wk Low
$6.49

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.75 December 11 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 3 3
(3) HOLD 0 0 1 1
(4) UNDERPERFORM 1 1 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 0.80 1.60 0.00 --
Quarter Ending Mar-19 2 1.00 2.00 0.00 --
Year Ending Dec-18 6 3.07 3.80 2.27 5.00
Year Ending Dec-19 6 9.65 18.60 0.00 7.42
Earnings (per share)
Quarter Ending Dec-18 6 -0.75 -0.61 -0.96 -3.03
Quarter Ending Mar-19 3 -0.80 -0.70 -0.91 --
Year Ending Dec-18 6 -2.81 -2.62 -3.01 -5.65
Year Ending Dec-19 6 -3.35 -2.59 -4.08 -10.11
LT Growth Rate (%) 1 40.40 40.40 40.40 0.60

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.58 0.66 0.07 12.48
Quarter Ending Jun-18 1.94 0.46 1.47 76.10
Quarter Ending Mar-18 0.28 1.15 0.87 311.79
Quarter Ending Dec-17 0.33 0.99 0.66 198.83
Quarter Ending Sep-17 0.20 0.60 0.40 203.51

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.80 0.80 0.83 0.76 --
Quarter Ending Mar-19 1.00 1.00 2.00 2.00 --
Year Ending Dec-18 3.07 3.07 3.18 2.98 5.00
Year Ending Dec-19 9.65 9.65 9.74 8.91 7.42

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 1
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 1 1
Earnings